Skip to content

Clinical trials

Observational Purpura, Thrombocytopenic, Idiopathic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Observational Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20112
20123
20133
20191
20211
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Weill Medical College of Cornell University3
Boston Children's Hospital2
Novartis Pharmaceuticals2
Beth Israel Medical Center1
Emory University1
Massachusetts General Hospital1
National Heart, Lung, and Blood Institute (NHLBI)1
Rigel Pharmaceuticals1
Sanguine Biosciences1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic15
Acquired Immunodeficiency Syndrome2
Autoimmune Diseases2
Hemorrhage2
Lupus Erythematosus, Systemic2
Myositis2
Scleroderma, Diffuse2
Sjogren's Syndrome2
Thrombocytopenia2
Alopecia Areata1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.